PepGen (PEPG) Total Liabilities (2021 - 2026)
PepGen (PEPG) reported Total Liabilities of $22.3 million for Q1 2026, down 37.3% on a YoY basis from $35.6 million in Q1 2025, and down 15.67% sequentially from $26.5 million in Q4 2025.
PepGen (PEPG) Total Liabilities (2021 - 2026) Analysis & Trends
PepGen (PEPG) has 6 years of Total Liabilities data on file, last reported at $22.3 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities fell 37.3% year-over-year to $22.3 million; the trailing twelve-month figure through Mar 2026 stood at $22.3 million (down 37.3% YoY), and the FY2025 full-year result was $26.5 million, down 17.98% from the prior year.
- Total Liabilities fell to $22.3 million in Q1 2026, from $26.5 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $38.5 million in Q2 2024 to a low of $15.5 million in Q3 2022.
- A 5-year average of $29.9 million and a median of $32.3 million in 2024 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities jumped 258.48% in 2022 and sank 37.3% in 2026, its largest moves.
- Tracing PEPG's Total Liabilities over 5 years: stood at $37.8 million in 2022, then declined by 8.41% to $34.6 million in 2023, then dropped by 6.84% to $32.3 million in 2024, then decreased by 17.98% to $26.5 million in 2025, then decreased by 15.67% to $22.3 million in 2026.
- Business Quant data shows PEPG's Total Liabilities at $22.3 million in Q1 2026, $26.5 million in Q4 2025, and $26.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - | 22.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.32 Mn |
| Dec 31, 2025 | 26.46 Mn |
| Sep 30, 2025 | 26.92 Mn |
| Jun 30, 2025 | 31.08 Mn |
| Mar 31, 2025 | 35.59 Mn |
| Dec 31, 2024 | 32.26 Mn |
| Sep 30, 2024 | 32.78 Mn |
| Jun 30, 2024 | 38.47 Mn |
| Mar 31, 2024 | 28.00 Mn |
| Dec 31, 2023 | 34.63 Mn |
| Sep 30, 2023 | 38.41 Mn |
| Jun 30, 2023 | 34.80 Mn |
| Mar 31, 2023 | 36.20 Mn |
| Dec 31, 2022 | 37.81 Mn |
| Sep 30, 2022 | 15.52 Mn |
| Jun 30, 2022 | 20.58 Mn |
| Mar 31, 2022 | 16.29 Mn |
| Dec 31, 2021 | 10.55 Mn |